This inventor holds 14 USPTO granted patents and 4 published patent applications, plus 2 CIPO patents and 2 EPO patents. Top assignees: Havah Therapeutics Pty Ltd., Chavah Pty Ltd.. Active years: 2015-2025.
Location History:
- Medindie, AU (2015 - 2017)
- Piccadilly, AU (2016 - 2021)
- Picadilly, AU (2022 - 2024)
Company Filing History:
Years Active: 2015-2025
Title: Stephen Nigel Birrell: Innovator in Breast Health
Introduction
Stephen Nigel Birrell is a prominent inventor based in Piccadilly, Australia, known for his innovative contributions to breast health. With a remarkable portfolio of 14 patents, he has dedicated his career to developing methods and compositions aimed at reducing mammographic breast density and associated cancer risks. His work has significant implications for women's health, particularly in the realms of hormonal therapies and breast tissue management.
Latest Patents
Among his latest patents, Birrell has introduced groundbreaking methods for treating mammographic breast density and stiffness. One of his notable patent disclosures outlines a comprehensive approach involving the administration of androgenic agents and aromatase inhibitors designed for patients at different life stages, including pre-menopausal, peri-menopausal, and post-menopausal women. This approach not only seeks to reduce breast pain but also targets elasticity and mechano-transduction issues at the genomic level within breast cells.
Additionally, Birrell has developed novel pharmaceutical formulations and delivery systems that ensure a sustained, multi-phasic release of therapeutic agents. These formulations aim to stabilize breast tissue and enhance androgen receptor expression, which can be critical in managing conditions like autoimmune inflammatory mastitis (AIM).
Career Highlights
Stephen Nigel Birrell’s career is marked by significant contributions to medical research and innovation. His dedication to advancing women's healthcare has positioned him as a key figure in the research community. Through his work, he has bridged gaps in understanding the hormonal impacts on breast health, thereby improving treatment options available to women.
Collaborations
Birrell has collaborated with various organizations, most notably with Havah Therapeutics Pty Ltd and Chavah Pty Ltd. His partnerships with these companies reflect a shared commitment to developing effective therapeutic solutions and enhancing patient outcomes in breast health.
Conclusion
In conclusion, Stephen Nigel Birrell exemplifies the spirit of innovation in medical technology and women's health. His extensive research and patent portfolio highlight significant advancements in addressing critical issues such as breast density and cancer risk. As he continues to pave the way for future developments, his work remains pivotal in improving the quality of life for many women.